Dr. Semira Abdi Beshir

Assistant professor Department of pharmacy practice

Educational background

  • B. Pharm from Addis Ababa University, Ethiopia in 2006
  • M. Clinical Pharm from National University of Malaysia, Malaysia in 2008
  • Ph.D from University Malaya, Malaysia in 2018

Research interest

  • Drug use valuation
  • Cardiovascular pharmacotherapy
  • Geriatric pharmacotherapy

Selected publications

  • Hamad. F., Elnour. A.A., Elamin. A., Mohamed. S., Yousif. I., Don. J., Abdi. S., Al Amoodi. A., Fathelrahman. A.I., Sam. K.G., Alanzi. F., Abubakar. A.B., Magboul. S.M., Ahmed. S.A., Sadeq. A. Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction. Curr Diabetes Rev. 2021;17(3):280-292. [link]
  • Elnour. A.A., Sadeq. A., Don. J., Hamad. F., El Khidir. I.Y., Abubakar. A.B., Elamin. A., Al Amoodi. A., Abdi. S., Sam. K.G., Suliman. S.M.E., Alhajri. N., Fathelrahman. A.I., Elnour. S.A.A. Scoping review of six retrospective studies: risk factors associated with the case fatality rate of people infected with Coronavirus (COVID-19). Sys Rev Pharm 2021;12(1):1526-1539. [link]
  • Elnour. A.A., Don. J., Yousif. I., Sam. K.G., Abdi. S., Alhajri. N., Al Amoodi. A., Fathelrahman. A.I., Magboul. S.M., Asim. S., Sadeq. A. The Early Mortality Rate of People Infected with Coronavirus (2019-nCoV) in Wuhan, China: Review of Three Retrospective Studies. J Pharm Bioallied Sci. 2020. 12(3): 223–233. [link]
  • Beshir, S., Hussain, N., Elnor, A. and Said, A., 2021. Umbrella Review on Non-Statin Lipid-Lowering Therapy. Journal of Cardiovascular Pharmacology and Therapeutics, p.107424842110029. [link]
  • Thomas, D., Beshir, S.A., Zachariah, S., Gnana, K., Hamdy H. Distance assessment of counselling skills using virtual patients during the COVID-19 pandemic.  Pharmacy Education, 2020; 20(2):196 – 204. [link]
  • Semira A. Beshir, Zoriah Aziz, Lok Bin Yap, Kok-Han Chee, and Yoke-Lin Lo. Evaluation of the predictive performance of bleeding risk scores in patients with nonvalvular atrial fibrillation on oral anticoagulants. Journal of Clinical Pharmacy and Therapeutics. 2017; 1–11. [link]
  • Semira A. Beshir, Lok Bin Yap, Szyuin Sim, Kok-Han Chee, Yoke-Lin Lo. Assessment of Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Malaysian Patients with Nonvalvular Atrial Fibrillation. Journal of Pharmacy and Pharmaceutical Sciences. 2017. 20(1): 365-377. [link]
  • Semira A. Beshir, Chee, Kok-Han, Lo, Yoke-Lin. Factors Associated with Abrupt Discontinuation of Dabigatran Therapy in Patients with Atrial Fibrillation in Malaysia. International Journal of Clinical Pharmacy. (2016) 38:1182–1190.[ link]
  • Semira A. Beshir and Nur Hamimi Bt Hamzah. Health Promotion and Health Education: Perception, Barriers and Standard of Practices of Community Pharmacists. International Journal of Health Promotion and Education (IJHPE). [link]
  • Semira A. Beshir, Monalina A Hanipah. Knowledge, Perception, Practice and Barriers of Breast Cancer Health Promotion Activities among Community Pharmacists in Two Districts of Selangor State, Malaysia. Asian Pacific Journal of Cancer prevention (APJCP). Vol 13 (9): 2012, 4427-4430 [link]